What are the Historical Developments and Current Growth Metrics of the Pneumothorax Treatment Devices Market?
The pneumothorax treatment devices market has seen considerable growth due to a variety of factors.
• There has been a swift expansion in the pneumothorax treatment devices market size in the past few years. Its growth is projected to rise from $3.62 billion in 2024 to $4.01 billion in 2025, signifying a compound annual growth rate (CAGR) of 10.6%.
This acceleration over the historic period is mostly due to increasing cases of pneumothorax, heightened awareness of the condition, development of emergency and trauma care facilities and a growing elderly population, coupled with an increase in surgical procedures.
What Is The Projected Growth Of The Pneumothorax Treatment Devices Market?
The pneumothorax treatment devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations suggest that the pneumothorax treatment devices market will experience significant expansion within the coming years, with an anticipated size of $5.94 billion in 2029, accompanied by a compound annual growth rate (CAGR) of 10.3%.
This projected development over the forecast period is attributable to factors such as a rise in respiratory diseases, an increase in thoracic surgeries, heightened investment in healthcare infrastructure, enhanced diagnostic methods, and a shift towards preventative healthcare. Key trends forecasted for this period involve advancements in medical device technology, evolved chest drainage systems, development in automated thoracic catheters, progress in minimally invasive procedures, and amalgamation with telemedicine.
What Main Forces Are Fueling Expansion In The Pneumothorax Treatment Devices Market?
The rise in respiratory illnesses is anticipated to spur the expansion of the pneumothorax treatment devices market. These health issues, which affect the lungs and airways, hinder breathing and oxygen exchange. The growth in respiratory illnesses can be linked to factors such as exposure to air pollutants, smoking, viral infections, and increased contact with allergens. Pneumothorax treatment devices, used to manage lung collapse and re-establish standard breathing in respiratory diseases, offer a solution. For instance, the American Lung Association, revealed in June 2024 that about 44.2 million Americans, which makes up 13.5% of the population, were diagnosed with asthma by a certified health professional in 2022. Hence, the surge in respiratory diseases is a significant driver for the pneumothorax treatment devices market expansion.
What Are The Principal Market Segments In The Global Pneumothorax Treatment Devices Healthcare Industry?
The pneumothorax treatment devices market covered in this report is segmented –
1) By Type: Ventilator Devices, Thoracic Vent Devices, Other Types
2) By Application: Traumatic Pneumothorax, Spontaneous Pneumothorax, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Ventilator Devices: Portable Ventilators, Non-Invasive Ventilators, Invasive Ventilators
2) By Thoracic Vent Devices: Chest Drainage Systems, Heimlich Valves, One-Way Chest Valve Systems
3) By Other Types: Needle Aspiration Devices, Pleural Catheters, Oxygen Therapy Devices
Pre-Book The Pneumothorax Treatment Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Pneumothorax Treatment Devices Market?
Leading businesses in the pneumothorax treatment devices market are concentrating on designing technologically sophisticated solutions, including chest X-ray solutions, to maintain their market dominance. Chest X-ray solutions are imaging systems, gear, and technology devised to produce in-depth radiographic pictures of the chest, comprising the lungs, heart, ribs, and related structures. For instance, Qure.ai, a health tech firm in the US, disclosed in September 2023 that the FDA had granted it 510(k) clearance for its novel chest X-ray solution, qXR-PTX-PE. The solution aims to aid in detecting pneumothorax (PTX) and pleural effusion (PE) quickly. The software, enabled by artificial intelligence, significantly advances care pathways in intensive care units (ICUs) and emergency rooms (ERs) by offering timely alerts to medical professionals. The qXR-PTX-PE solution scrutinizes chest X-ray images for vital findings, markedly amplifying triage competence in emergency contexts where these illnesses potentially jeopardize patient health.
Who Are the Key Players in the Pneumothorax Treatment Devices Market?
Major companies operating in the pneumothorax treatment devices market are include:
• Cardinal Health Inc.
• Medtronic PLC
• Siemens Healthineers AG
• Medline Industries Inc.
• Fujifilm Holdings Corporation
• Becton Dickinson and Company (BD)
• GE HealthCare Technologies Inc.
• Stryker Corporation
• Boston Scientific Corporation
• Draegerwerk AG & Co. KGaA
• Cook Medical Inc.
• B. Braun Melsungen AG
• Utah Medical Products Inc.
• Rocket Medical plc
• Nobelpharma Co. Ltd.
• Sinapi Biomedical Inc.
• UreSil Inc.
• ATMOS MedizinTechnik GmbH & Co. KG
• Betaglue Technologies S.p.A.
• Selio Medical Inc.
What are the Regional Insights into the Pneumothorax Treatment Devices Market?
North America was the largest region in the pneumothorax treatment devices market in 2024. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
